Pepper MS - Search Results

1

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.

Persaud K, Tille JC, Liu M, Zhu Z, Jimenez X, Pereira DS, Miao HQ, Brennan LA, Witte L, Pepper MS, Pytowski B. Persaud K, et al. Among authors: pepper ms. J Cell Sci. 2004 Jun 1;117(Pt 13):2745-56. doi: 10.1242/jcs.01138. Epub 2004 May 18. J Cell Sci. 2004. PMID: 15150322

2

Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro.

Tille JC, Pepper MS. Tille JC, et al. Among authors: pepper ms. Exp Cell Res. 2002 Nov 1;280(2):179-91. doi: 10.1006/excr.2002.5635. Exp Cell Res. 2002. PMID: 12413884

3

Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro.

Tille JC, Wang X, Lipson KE, McMahon G, Ferrara N, Zhu Z, Hicklin DJ, Sleeman JP, Eriksson U, Alitalo K, Pepper MS. Tille JC, et al. Among authors: pepper ms. Exp Cell Res. 2003 May 1;285(2):286-98. doi: 10.1016/s0014-4827(03)00053-3. Exp Cell Res. 2003. PMID: 12706123

4

Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.

Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS. Tille JC, et al. Among authors: pepper ms. J Pharmacol Exp Ther. 2001 Dec;299(3):1073-85. J Pharmacol Exp Ther. 2001. PMID: 11714897

5

Lymphangiogenesis and tumor metastasis.

Pepper MS, Tille JC, Nisato R, Skobe M. Pepper MS, et al. Cell Tissue Res. 2003 Oct;314(1):167-77. doi: 10.1007/s00441-003-0748-7. Epub 2003 Jul 18. Cell Tissue Res. 2003. PMID: 12883995 Review.

6

Lymphangiogenesis and tumor metastasis.

Nisato RE, Tille JC, Pepper MS. Nisato RE, et al. Among authors: pepper ms. Thromb Haemost. 2003 Oct;90(4):591-7. doi: 10.1160/TH03-04-0206. Thromb Haemost. 2003. PMID: 14515178 Review.

7

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS. Nisato RE, et al. Among authors: pepper ms. Angiogenesis. 2003;6(2):105-19. doi: 10.1023/B:AGEN.0000011801.98187.f2. Angiogenesis. 2003. PMID: 14739617

8

Lymphangiogenesis and tumour metastasis.

Tille JC, Nisato R, Pepper MS. Tille JC, et al. Among authors: pepper ms. Novartis Found Symp. 2004;256:112-31; discussion 132-6, 259-69. Novartis Found Symp. 2004. PMID: 15027486 Review.

9

Familial predisposition to tufted angioma: identification of blood and lymphatic vascular components.

Tille JC, Morris MA, Bründler MA, Pepper MS. Tille JC, et al. Among authors: pepper ms. Clin Genet. 2003 May;63(5):393-9. doi: 10.1034/j.1399-0004.2003.00034.x. Clin Genet. 2003. PMID: 12752572

10

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.

Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. Van der Auwera I, et al. Among authors: pepper ms. Br J Cancer. 2006 Dec 18;95(12):1611-25. doi: 10.1038/sj.bjc.6603445. Epub 2006 Nov 21. Br J Cancer. 2006. PMID: 17117184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters